Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024

Vista Veterinary Hospital has been awarded one of America’s Best Animal Hospitals 2025

Vivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025

New Radiation Therapy in New Jersey is Showing Promise in Treating Cancer in Pets

Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

Vivos Inc Summarizes Progress in its Animal Therapy Division

Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing

Vivos Inc. Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™

Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update

Human Studies Begin for Hard-to-Treat Cancers. Treatment Invented in Tri-Cities